{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:48:16Z","timestamp":1784933296513,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T00:00:00Z","timestamp":1548028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671417"],"award-info":[{"award-number":["81671417"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370688"],"award-info":[{"award-number":["81370688"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Medical Center of Key Programs for Female Reproductive Diseases","award":["2017ZZ010616"],"award-info":[{"award-number":["2017ZZ010616"]}]},{"name":"Shanghai Science and Technology Development","award":["17411961000"],"award-info":[{"award-number":["17411961000"]}]},{"name":"Municipal Human Resources Development Program for Outstanding Leaders in Medical Disciplines in Shanghai","award":["2017BR035"],"award-info":[{"award-number":["2017BR035"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ygyno.2019.01.014","type":"journal-article","created":{"date-parts":[[2019,1,20]],"date-time":"2019-01-20T23:50:03Z","timestamp":1548028203000},"page":"55-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer"],"prefix":"10.1016","volume":"153","author":[{"given":"Bingyi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5493-1500","authenticated-orcid":false,"given":"Xiaojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2019.01.014_bb0005","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1006\/gyno.2001.6434","article-title":"Endometrial cancer in women 40\u202fyears old or younger","volume":"83","author":"Duska","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0010","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.AOG.0000154151.14516.f7","article-title":"Risk factors for young premenopausal women with endometrial cancer","volume":"105","author":"Soliman","year":"2005","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0015","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/cncr.21649","article-title":"Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Zaino","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2019.01.014_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygyno.2011.11.043","article-title":"Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature","volume":"125","author":"Baker","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0025","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.3802\/jgo.2016.27.e8","article-title":"Therapeutic options for management of endometrial hyperplasia","volume":"27","author":"Chandra","year":"2016","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0030","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/IGC.0000000000000669","article-title":"Management of endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: a Korean Gynecologic-Oncology Group study","volume":"26","author":"Kim","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2019.01.014_bb0035","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device","volume":"131","author":"Pal","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0045","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1634\/theoncologist.2013-0445","article-title":"Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer","volume":"20","author":"Park","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.ygyno.2019.01.014_bb0050","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jmig.2015.06.004","article-title":"Hysteroscopic resection in fertility-sparing surgery for atypical hyperplasia and endometrial cancer: safety and efficacy","volume":"22","author":"De Marzi","year":"2015","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jmig.2014.08.782","article-title":"Hysteroscopic resection in the management of early-stage endometrial cancer: report of 2 cases and review of the literature","volume":"22","author":"Arendas","year":"2015","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0060","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.3802\/jgo.2017.28.e2","article-title":"Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer","volume":"28","author":"Falcone","year":"2017","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0065","author":"National Comprehensive Cancer Network"},{"key":"10.1016\/j.ygyno.2019.01.014_bb0070","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.3802\/jgo.2018.29.e35","article-title":"Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients","volume":"29","author":"Yang","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0075","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/IGC.0000000000001008","article-title":"Gonadotropin-releasing hormone agonist combined with a levonorgestrel-releasing intrauterine system or letrozole for fertility-preserving treatment of endometrial carcinoma and complex atypical hyperplasia in young women","volume":"27","author":"Zhou","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2019.01.014_bb0080","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.fertnstert.2008.12.009","article-title":"Conservative surgical management of stage IA endometrial carcinoma for fertility preservation","volume":"93","author":"Mazzon","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0085","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00404-013-2826-8","article-title":"A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women","volume":"288","author":"Shan","year":"2013","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0090","first-page":"13804","article-title":"Fertility-conservation combined therapy with hysteroscopic resection and oral progesterone for local early stage endometrial carcinoma in young women","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0095","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1447-0756.2011.01558.x","article-title":"Prospective comparison of biopsy results from curettage and hysteroscopy in postmenopausal uterine bleeding","volume":"37","author":"Lee","year":"2011","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0100","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ygyno.2015.10.015","article-title":"Prognostic factors of regression and relapse of complex atypical hyperplasia and well-differentiated endometrioid carcinoma with conservative treatment","volume":"139","author":"Yang","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0105","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.fertnstert.2009.06.013","article-title":"Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium","volume":"92","author":"Yu","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2014.02.020","article-title":"Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin","volume":"133","author":"Simpson","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0115","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ejca.2012.09.017","article-title":"Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)","volume":"49","author":"Park","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2019.01.014_bb0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<139::AID-CNCR19>3.0.CO;2-U","article-title":"Does hysteroscopy facilitate tumor cell dissemination? Incidence of peritoneal cytology from patients with early stage endometrial carcinoma following dilatation and curettage (D & C) versus hysteroscopy and D & C","volume":"88","author":"Obermair","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2019.01.014_bb0125","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.fertnstert.2011.07.1146","article-title":"Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: a meta-analysis","volume":"96","author":"Chang","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0090-8258(92)90246-F","article-title":"Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease","volume":"46","author":"Kadar","year":"1992","journal-title":"Gynecol. Oncol."},{"issue":"71","key":"10.1016\/j.ygyno.2019.01.014_bb0135","first-page":"e1","article-title":"The risk of diagnostic hysteroscopy in women with endometrial cancer","volume":"207","author":"Soucie","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ygyno.2017.05.002","article-title":"Significance of body weight change during fertility-sparing progestin therapy in young women with early endometrial cancer","volume":"146","author":"Park","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/AOG.0b013e3182964ce3","article-title":"Hormonal therapy for women with stage IA endometrial cancer of all grades","volume":"122","author":"Park","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0150","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ajog.2015.03.037","article-title":"Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials","volume":"213","author":"Abu Hashim","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2019.01.014_bb0155","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ygyno.2015.12.010","article-title":"Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer","volume":"140","author":"Cholakian","year":"2016","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819300563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819300563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:41:43Z","timestamp":1758771703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825819300563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0090825819300563"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.01.014","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}